SRAD vs GENI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jun 21, 2026

SRAD

63.3
AI Score
VS
SRAD Wins

GENI

58.1
AI Score

Investment Advisor Scores

SRAD

63score
Recommendation
BUY

GENI

58score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric SRAD GENI Winner
Forward P/E 35.9712 56.8182 SRAD
PEG Ratio 0 0 Tie
Revenue Growth 11.3% 30.5% GENI
Earnings Growth -39.9% 0.0% GENI
Tradestie Score 63.3/100 58.1/100 SRAD
Profit Margin 5.3% -22.3% SRAD
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD SRAD

Frequently Asked Questions

Based on our detailed analysis, SRAD is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.